Filing Details
- Accession Number:
- 0000950170-24-021125
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-27 16:10:17
- Reporting Period:
- 2024-02-23
- Accepted Time:
- 2024-02-27 16:10:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1468328 | Addus Homecare Corp | ADUS | Services-Home Health Care Services (8082) | 205340172 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1774773 | Sean Gaffney | 6303 Cowboys Way Suite 600 Frisco TX 75034 | Evp/Chief Legal Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-02-23 | 5,657 | $0.00 | 19,641 | No | 4 | A | Direct | |
Common Stock | Disposition | 2024-02-26 | 1,639 | $85.95 | 18,002 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- The shares vest in equal installments on each of February 23, 2025, February 23, 2026, and February 23, 2027, subject to customary provisions for continued service and acceleration on a change in control.
- This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.94 to $85.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.